News
NKGN
0.2975
+12.73%
0.0336
Weekly Report: what happened at NKGN last week (1111-1115)?
Weekly Report · 11h ago
NKGEN BIOTECH INC: ON NOV 5, AS PART OF \GREATER COST-REDUCTION EFFORTS, CONDUCTED A GROUP LAYOFF OF 16 EMPLOYEES.
Reuters · 5d ago
Weekly Report: what happened at NKGN last week (1104-1108)?
Weekly Report · 11/11 11:12
Weekly Report: what happened at NKGN last week (1028-1101)?
Weekly Report · 11/04 11:10
NKGEN BIOTECH INC - ON OCT 24, CO PLACED 19 EMPLOYEES ON FURLOUGH, EFFECTIVE OCTOBER 27
Reuters · 10/30 21:24
NKGEN BIOTECH INC - PLANS FOR FURLOUGH TO LAST FROM OCTOBER 27 THROUGH NOVEMBER 9
Reuters · 10/30 21:24
NKGEN BIOTECH - CO'S INABILITY TO PAY ITS PAYROLL OBLIGATIONS MAY RESULT IN EMPLOYEES TERMINATING RELATIONSHIP WITH CO AND/OR PURSUING LEGAL REMEDIES
Reuters · 10/30 21:24
NKGen Biotech announces presentation of two posters in AD
TipRanks · 10/29 12:31
NKGEN BIOTECH PRESENTS PHASE 1/2A TROCULEUCEL DATA IN ALZHEIMER’S DISEASE AT THE 17TH ANNUAL CLINICAL TRIALS ON ALZHEIMER’S DISEASE (CTAD) CONFERENCE
Reuters · 10/29 12:05
Weekly Report: what happened at NKGN last week (1021-1025)?
Weekly Report · 10/28 11:02
Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/21 11:03
Weekly Report: what happened at NKGN last week (1014-1018)?
Weekly Report · 10/21 10:59
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 10/18 16:30
Dow Falls Over 100 Points; Netflix Posts Upbeat Results
Benzinga · 10/18 14:27
BUZZ-U.S. STOCKS ON THE MOVE-Crypto stocks, Apple
Reuters · 10/18 13:18
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 10/18 12:09
BUZZ-U.S. STOCKS ON THE MOVE-CVS Health Corp, Netflix, China ADRs
Reuters · 10/18 11:54
Why Intuitive Surgical Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/18 10:52
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 10/17 20:30
NKGen Biotech Announces Upcoming Presentation at the 16th World Stroke Congress (WSC 2024)
Barchart · 10/15 07:05
More
Webull provides a variety of real-time NKGN stock news. You can receive the latest news about NKGen Biotech Inc through multiple platforms. This information may help you make smarter investment decisions.
About NKGN
NKGen Biotech, Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapeutics. Its product candidates are based on a manufacturing and cryopreservation process, which produces SuperNK (SNK) cells. SNK cells can be produced in large quantities and cryopreserved, while maintaining high levels of cytotoxicity and activating receptor expression after thawing and reconstitution. It is developing SNK01, an autologous natural killer (NK) cell therapy, for the treatment of neurodegenerative diseases, including Alzheimer’s disease (AD) and Parkinson’s disease (PD). Its autologous NK cell therapy candidate has clinical trials in several therapeutic areas, including oncology and neurodegeneration. SNK02 is its allogeneic NK cell product candidate. It is conducting clinical trials with its SNK cell therapy in patients with neurodegenerative disease (SNK01) and cancer (SNK02).